Jeffrey W. Ubben
Jeffrey Ubben is a founder, the chief executive officer and the chief investment officer of ValueAct Capital, a San Francisco-based investment partnership with more than $6 billion in assets under management.
View Older Stories View More Recent Stories
-
Form SC 13D/A KKR & Co. L.P. Filed by: VA Partners I, LLC
-
Form 4 ValueAct Capital Master For: Sep 11 Filed by: WILLIS TOWERS WATSON PLC
-
Form 4 ValueAct Capital Master For: Sep 07 Filed by: TRINITY INDUSTRIES INC
-
Form 4 ValueAct Capital Master For: Sep 06 Filed by: WILLIS TOWERS WATSON PLC
-
David Kramer, Jay Sures Named Co-Presidents of United Talent Agency
-
Form 4 ValueAct Capital Master For: Aug 31 Filed by: WILLIS TOWERS WATSON PLC
-
Form SC 13D/A KKR & Co. L.P. Filed by: VA Partners I, LLC
-
Form SC 13D/A Seagate Technology plc Filed by: VA Partners I, LLC
-
Form 4 ValueAct Capital Master For: Aug 29 Filed by: TRINITY INDUSTRIES INC
-
Form 4 ValueAct Capital Master For: Aug 25 Filed by: WILLIS TOWERS WATSON PLC
-
Form 4 ValueAct Capital Master For: Aug 23 Filed by: TRINITY INDUSTRIES INC
-
Form 4 ValueAct Capital Master For: Aug 22 Filed by: WILLIS TOWERS WATSON PLC
-
Form 4 ValueAct Capital Master For: Aug 18 Filed by: TRINITY INDUSTRIES INC
-
Form 4 ValueAct Capital Master For: Aug 17 Filed by: WILLIS TOWERS WATSON PLC
-
Form SC 13D KKR & Co. L.P. Filed by: VA Partners I, LLC
-
Form SC 13D/A TRINITY INDUSTRIES INC Filed by: VA Partners I, LLC
-
Form 4 ValueAct Capital Master For: Aug 15 Filed by: TRINITY INDUSTRIES INC
-
Form 4 WILLIS TOWERS WATSON For: Aug 14 Filed by: ValueAct Capital Master Fund, L.P.
-
Form 4 ValueAct Capital Master For: Aug 10 Filed by: TRINITY INDUSTRIES INC
-
Form 4 ValueAct Capital Master For: Aug 10 Filed by: WILLIS TOWERS WATSON PLC
-
Form 13F-NT ValueAct Capital Managem For: Jun 30
-
ValueAct Capital Raises Stake in Seagate Technology (STX) to 7.2% - 13D
-
Form SC 13D Seagate Technology plc Filed by: VA Partners I, LLC
-
Form 4 ValueAct Capital Master For: Aug 07 Filed by: TRINITY INDUSTRIES INC
-
Form 4 ValueAct Capital Master For: Aug 07 Filed by: WILLIS TOWERS WATSON PLC
-
Form SC 13D Baker Hughes a GE Co Filed by: VA Partners I, LLC
-
Form 4 ValueAct Capital Master For: Aug 02 Filed by: TRINITY INDUSTRIES INC
-
Form SC 13D/A Bioverativ Inc. Filed by: VA Partners I, LLC
-
KKR names Bae, Nuttall as co-presidents in step toward succession
-
Form 4 TWENTY-FIRST CENTURY For: Jul 03 Filed by: UBBEN JEFFREY W
-
Hedge fund Paulson & Co discloses 6.3 percent stake in Valeant
-
Form SC 13D/A ALLIANCE DATA SYSTEMS Filed by: VA Partners I, LLC
-
Form SC 13D/A WILLIS TOWERS WATSON Filed by: VA Partners I, LLC
-
Form 4 WILLIS TOWERS WATSON For: May 25 Filed by: VA Partners I, LLC
-
Form 4 CBRE GROUP, INC. For: May 19 Filed by: VA Partners I, LLC
-
Form 4 WILLIS TOWERS WATSON For: May 17 Filed by: VA Partners I, LLC
-
ValueAct trims stake in Morgan Stanley in first quarter
-
Form 4 CBRE GROUP, INC. For: May 11 Filed by: ValueAct Capital Master Fund, L.P.
-
Form 13F-NT ValueAct Capital Managem For: Mar 31
-
ValueAct's Ubben taps Morfit for CIO post in succession plan
-
Form SC 13D/A CBRE GROUP, INC. Filed by: VA Partners I, LLC
-
ValueAct's Jeff Ubben will hands day-to-day oversight of the portfolio to Mason Morfit - FT
-
Activist ValueAct says invested in private equity pioneer KKR
-
ValueAct's Ubben to Return $1.25B to Investors Amid 'Skeptical' View of Current Market - CNBC
-
Form SC 13D/A ALLIANCE DATA SYSTEMS Filed by: VA Partners I, LLC
-
ValueAct boosts Valeant stake after Pershing exits
-
Form SC 13D Valeant Pharmaceuticals Filed by: VA Partners I, LLC
-
ValueAct Buys 3M Valeant Pharma (VRX) Shares
-
Microsoft (MSFT) Declares $0.39 Quarterly Dividend; Names Reid Hoffman to Board
-
Microsoft announces addition to board and quarterly dividend

